-
Recent Posts
- Strategies for Regeneration | Arthur Brown |
- CPAR: Joel Burdick from Caltech on Epidural Spinal Stimulation
- What does “Disruptive” mean? Thoughts on the NIH SCI 2020 meeting
- Combined administration of electro-magnetic stimulation (EMS) at spinal level and at leg muscles to modulate neurophysiological properties at spino-muscular circuitry in healthy and SCI humans
- Spinal Modulation for Rehabilitation | Reggie Edgerton, PhD
- Spinal Neuromodulation for Motor Control and Beyond | Daniel Lu. MD, PhD
- Efforts underway to bring treatments to Australia
- NervGen looking to use their technology to revolutionize nerve damage treatment
- Enhancement of plasticity for functional recovery after spinal cord injury
- University of Technology Sydney: Reviving Hope
- How paralyzed people are learning to walk
- Edonerpic maleate boosts motor function recovery from spinal cord injury
- Opinion: Ethical Challenges in Using iPS Cells to Treat Paralysis
- Mechanisms of noradrenergic modulation of synaptic transmission and neuronal excitability in ventral horn neurons of the rat spinal cord
- Marquette receives $500,000 for research from the Bryon Riesch Foundation
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: Jan-Eric Ahlfors
Human Oligodendrogenic Neural Progenitor Cells Delivered with Chondroitinase ABC Facilitate Functional Repair of Chronic Spinal Cord Injury
Authors: Satoshi Nori, Mohamad Kahazaei, Christopher S. Ahuja, Kazuya Yokota, Jan-Eric Ahlfors, Yang Liu, Jain Wang, Shinsuke Shibata, Jonathon Chio, Marian H Hettiaratchi, Tobias Fuhrmann, Molly S. Shoichet, Michael G. Gehlings Summary: “Treatment of chronic spinal cord injury (SCI) is … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged Christopher S. Ahuja, Jain Wang, Jan-Eric Ahlfors, Jonathon Chio, Kazuya Yokota, Marian H Hettiaratchi, Michael G. Gehlings, Mohamad Kahazaei, Molly S. Shoichet, Satoshi Nori, Shinsuke Shibata, Tobias Fuhrmann, Yang Liu
2 Comments
Fortuna Fix Announces Series B Financing, Adding Amgen Ventures and Macnguyen Family Office as Shareholders
(Newswire.com) Press Release: November 8, 2017 Fortuna Fix – Fortuna Fix (“Fortuna”), a private, clinical-stage Regenerative Medicine company is aiming to be the first to bring to the clinic a patient’s own neural stem cells (autologous) produced by direct reprogramming … Continue reading
Breakthrough Regenerative Therapeutics Company Establishes Scientific Advisory Board
Montreal, Canada, May 4, 2017 (Newswire.com) – Fortuna Fix Inc. (“Fortuna”), a private, clinical-stage biotech company, is aiming to be the first to eliminate the need for embryonic and fetal stem cells by using direct reprogramming of autologous cells to treat … Continue reading
Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged Jan-Eric Ahlfors, MPH; and Professor James Giordano, PhD; Col. (R) Dallas Hack, PhD; Father Kevin FitzGerald, Professor Michael Fehlings
1 Comment
New World Laboratories pushes forward with clinical trial
New World Laboratories acts as its own research center, allowing it to create its own therapeutic platforms. The company focuses its efforts on three main sectors—therapeutic drugs, medical devices, and cell therapies. For example, the apoptosis program (programmed cell death) … Continue reading
